Results of a Phase 1, Open-label,Dose-escalation Study of Gene Therapy with AAV2-hAQP1 as Treatment for Grade 2 and 3 Radiation-induced Late Xerostomia and Parotid Gland Hypofunction -.
Cancer-related fatigue is one of the most underestimated and least researched side effects, said an oncology consultant who spoke at the European Society for Medical Oncology s 2023 Conference.
Long-term assessments did not reveal differences in patient-reported outcomes between primary surgery or radiotherapy for patients with oropharyngeal squamous cell carcinoma.